Publication | Closed Access

Gemcitabine and vinorelbine as second-line therapy in non-small-cell lung cancer after prior treatment with taxane+platinum-based regimens

Non-small-cell Lung CancerMedicinePharmacologyBronchial NeoplasmPrior TreatmentAnti-cancer AgentCancer TreatmentSecond-line TherapyOncologyRadiation OncologyLung Cancer